Modification of the Ti15Mo alloy surface through TiO 2 nanotube growth—an in vitro study
Source abstract
Abstract
In this study, ordered and uniform TiO 2 nanotubular structures were obtained on the surface of the Ti15Mo alloy by anodic oxidation. The amorphous state of TiO 2 nanotubes formed under different anodization conditions was investigated. Crystallization of TiO 2 into anatase phase occurs during annealing at temperatures of around 400°C, whereas anatase to rutile transformation starts around 500°C and is completed at 800°C. Phase transformations in annealed samples led to morphological changes of tubular nanostructures, suggesting that the oxide layer formed at the nanotube/substrate interface serves as nucleation sites for more stable phases of TiO 2 . The proliferation of fibroblasts cells under annealing conditions of 450°C, and of untreated samples (control group), was evaluated after 1, 4, and 7 days in cell culture using fluorescence microscopy images. A gradual increase in the number and size of cells was observed, indicating a non-toxic alloy. There was also better surface coverage on anodized samples compared with the untreated group; as well as increased development of the cytoskeleton in samples after anodization. The results of this study showed that the growth of TiO 2 nanotubular structures associated with annealing allow better cell adhesion on the Ti15Mo alloy surface.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Titanium Alloys Microstructure and Properties · Marine Biology and Environmental Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials and Technology, School of Engineering, São Paulo State University (UNESP), Guaratinguetá, Brazil
Department of Mechanical Engineering, School of Biomedical Engineering, Colorado State University, Fort Collins, CO, USA
References (28)
Show source-provided references
1. Sobieszczyk S · Adv Mater Sci · 2010 · 10 · 29
2. 10.1016/j.elecom.2014.06.02110.1016/j.elecom.2014.06.021 ↗
3. 10.1002/smll.20120056410.1002/smll.201200564 ↗
4. 10.1002/jbm.a.3457510.1002/jbm.a.34575 ↗
5. 10.1016/j.tsf.2013.08.09610.1016/j.tsf.2013.08.096 ↗
6. 10.1016/j.tsf.2015.12.00110.1016/j.tsf.2015.12.001 ↗
7. 10.1021/jp210793u10.1021/jp210793u ↗
8. 10.1002/smll.20070124410.1002/smll.200701244 ↗
9. 10.1016/j.msec.2012.05.01310.1016/j.msec.2012.05.013 ↗
10. Yu WQ · J Biomed Mater Res A · 2010 · 94 · 1012
11. 10.1016/j.apsusc.2016.02.01710.1016/j.apsusc.2016.02.017 ↗
12. 10.1016/j.msec.2017.02.15010.1016/j.msec.2017.02.150 ↗
13. 10.1007/s40735-015-0024-x10.1007/s40735-015-0024-x ↗
14. 10.1016/j.actbio.2012.04.00510.1016/j.actbio.2012.04.005 ↗
15. 10.1002/sia.318310.1002/sia.3183 ↗
16. 10.1016/j.apsusc.2014.04.04010.1016/j.apsusc.2014.04.040 ↗
17. 10.1016/j.apsusc.2013.08.04110.1016/j.apsusc.2013.08.041 ↗
18. 10.1016/j.tsf.2009.03.16510.1016/j.tsf.2009.03.165 ↗
19. 10.1002/ejic.20100060810.1002/ejic.201000608 ↗
20. 10.1016/j.cattod.2016.01.01610.1016/j.cattod.2016.01.016 ↗
21. 10.1016/j.jallcom.2006.08.31710.1016/j.jallcom.2006.08.317 ↗
22. 10.1088/0022-3727/33/8/30510.1088/0022-3727/33/8/305 ↗
23. 10.1039/c0jm03106b10.1039/c0jm03106b ↗
24. 10.1016/j.vibspec.2004.05.00610.1016/j.vibspec.2004.05.006 ↗
25. 10.1016/j.jpcs.2013.09.00810.1016/j.jpcs.2013.09.008 ↗
26. 10.4028/www.scientific.net/MSF.899.19510.4028/www.scientific.net/MSF.899.195 ↗
27. 10.1002/jbm.a.3072210.1002/jbm.a.30722 ↗
28. 10.4028/www.scientific.net/MSF.888.26210.4028/www.scientific.net/MSF.888.262 ↗